Interstitial Lung Disease
Conditions
Keywords
Progressive Fibrosing Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease Associated With Systemic Sclerosis, Myositis-Associated Interstitial Lung Disease, Sarcoidosis, Hypersensitivity Pneumonitis, Pulmonary Fibrosis
Brief summary
The purpose of this research study is to build and maintain a registry of people with interstitial lung disease (ILD). Medical information collected for this registry may be used to advance ILD and pulmonary research and improve patient care. This is an observational registry. Participants will not receive any investigational treatments or investigational drugs as part of their participation in this registry.
Detailed description
The registry will contain longitudinal medical histories of ILD patients. The creation and curation of the registry with utilize release of information services, biomedical informatics methods and human expert reviews. Among the registry's long-term goals is to utilize its data and informatics resources to study and advance ILD diagnosis and treatment. The registry will be developed with a set of capabilities to consistently, repeatedly, and economically build research-grade datasets that allow cohort development from natively unstructured and non-standard phenotypic clinical and imaging data.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* People with a confirmed diagnosis of interstitial lung disease by a primary care physician and/or pulmonologist.
Exclusion criteria
\-
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Development and implementation of a database populated with de-identified longitudinal medical histories of interstitial lung disease patients. | Up to 18 months |
Secondary
| Measure | Time frame |
|---|---|
| Advancing the understanding of the natural course and the treatments of interstitial lung diseases. | Up to 18 months |
Countries
United States